Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab
2015 ◽
Vol 3
(1)
◽
pp. 29229
◽
2018 ◽
Vol 12
(supplement_1)
◽
pp. S314-S314
Keyword(s):
2017 ◽
Vol 2
(4)
◽
pp. 228-235
◽
Keyword(s):
2014 ◽
Vol 20
(1)
◽
pp. 214
◽
Keyword(s):
2018 ◽
Vol 12
(supplement_1)
◽
pp. S396-S397
2007 ◽
Vol 26
(11-12)
◽
pp. 1509-1520
◽